- Home
- BSTZ vs GPCR Comparison
BSTZ vs GPCR Comparison
Compare BSTZ & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- GPCR
- Stock Information
- Founded
- BSTZ 2019
- GPCR 2016
- Country
- BSTZ United States
- GPCR United States
- Employees
- BSTZ N/A
- GPCR N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- GPCR
- Sector
- BSTZ Finance
- GPCR
- Exchange
- BSTZ Nasdaq
- GPCR Nasdaq
- Market Cap
- BSTZ 1.5B
- GPCR 1.2B
- IPO Year
- BSTZ N/A
- GPCR 2023
- Fundamental
- Price
- BSTZ $22.73
- GPCR $29.57
- Analyst Decision
- BSTZ
- GPCR Strong Buy
- Analyst Count
- BSTZ 0
- GPCR 8
- Target Price
- BSTZ N/A
- GPCR $69.57
- AVG Volume (30 Days)
- BSTZ 303.2K
- GPCR 914.1K
- Earning Date
- BSTZ 01-01-0001
- GPCR 11-13-2025
- Dividend Yield
- BSTZ 8.31%
- GPCR N/A
- EPS Growth
- BSTZ N/A
- GPCR N/A
- EPS
- BSTZ 0.71
- GPCR N/A
- Revenue
- BSTZ N/A
- GPCR N/A
- Revenue This Year
- BSTZ N/A
- GPCR N/A
- Revenue Next Year
- BSTZ N/A
- GPCR N/A
- P/E Ratio
- BSTZ $26.69
- GPCR N/A
- Revenue Growth
- BSTZ N/A
- GPCR N/A
- 52 Week Low
- BSTZ $14.11
- GPCR $13.22
- 52 Week High
- BSTZ $19.43
- GPCR $42.57
- Technical
- Relative Strength Index (RSI)
- BSTZ 61.99
- GPCR 62.44
- Support Level
- BSTZ $21.02
- GPCR $25.59
- Resistance Level
- BSTZ $23.12
- GPCR $27.49
- Average True Range (ATR)
- BSTZ 0.41
- GPCR 1.47
- MACD
- BSTZ 0.04
- GPCR -0.19
- Stochastic Oscillator
- BSTZ 81.47
- GPCR 72.49
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.